In 1984 Ting was hired as an assistant professor at the University of North Carolina. She was promoted to associate professor in 1990 and full professor in 1993. She received a named professorship in 2009, becoming the William Rand Kenan Professor. Since 1991 she has been leader of the immunology program at UNC Lineberger Comprehensive Cancer Center. She has been director of its Center for Translational Immunology and co-director of its Institute of Inflammatory Diseases since 2008.[2] Ting's research areas include the NLR gene family, which act as regulators of inflammation. She also researches vaccine adjuvants, including the possible use of nanoparticles and microparticles, for cancers that are difficult to treat like triple-negative breast cancer or for infectious diseases like dengue fever or zika fever.[3]
Ting was elected to the Henry Kunkel Society and the Academia Sinica in 2015. In 2015 and 2016 she was a Thomas Reuter Highly Cited Researcher; in 2018 and 2019 she was a Clarivate/Analytics Highly Cited Researcher. She was vice president of the American Association of Immunologists from 2019 to 2020[3] and named the president for 2020 to 2021. She was the first woman of color to serve as the organization's president.[5]
In 2010, she was inducted into the Illinois State University College of Applied Science and Technology Hall of Fame.[1] She received the NCI Outstanding Investigator Award from 2016 to 2019.[3] In 2022, she was elected as a member of the National Academy of Sciences[6] and the American Academy of Arts and Sciences.[7]
